XML 37 R30.htm IDEA: XBRL DOCUMENT
v3.25.4

The Company and Basis of Presentation (Tables) | 6 Months Ended
--- | ---
Dec. 31, 2025
The Company and Basis of Presentation [Abstract] |
Schedule of Company’s Entity Structure at the End of the Reporting Period | Details of the Company’s entity structure at the end of the reporting period are as follows (post-redomiciliation):
Name |  | Entity |  | Country of Incorporation
Neuphoria Therapeutics Inc. |  | Parent |  | United States
Bionomics Limited |  | Subsidiary |  | Australia
Bionomics, Inc. |  | Subsidiary |  | United States

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration